Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02781935Completed

Diffusion-Weighted MRI for Liver Metastasis

Role: collaborator

NCT02218801Completed

A Prospective Colorectal Liver Metastasis Database With an Integrated Quality Assurance Program

Role: collaborator

NCT03299270Unknown

Geriatric Oncology Surgical Assessment and Functional rEcovery After Surgery

Role: collaborator

NCT03351959Unknown

Complete Pathologic Response Rectal Cancers

Role: collaborator

All 4 trials loaded